DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Haloperidol Decanoate is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, West-ward Pharms Int, and Zydus Pharms. and is included in ten NDAs.
The generic ingredient in HALOPERIDOL DECANOATE is haloperidol decanoate. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
A generic version of HALOPERIDOL DECANOATE was approved as haloperidol decanoate by FRESENIUS KABI USA on December 19th, 1997.
Summary for HALOPERIDOL DECANOATE
|Finished Product Suppliers / Packagers:||9|
|Raw Ingredient (Bulk) Api Vendors:||36|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for HALOPERIDOL DECANOATE|
|What excipients (inactive ingredients) are in HALOPERIDOL DECANOATE?||HALOPERIDOL DECANOATE excipients list|
|DailyMed Link:||HALOPERIDOL DECANOATE at DailyMed|
Recent Clinical Trials for HALOPERIDOL DECANOATE
Identify potential brand extensions & 505(b)(2) entrants
|Case Western Reserve University||Phase 3|
|National Institutes of Health (NIH)||Phase 3|
|University of North Carolina, Chapel Hill||Phase 4|
Pharmacology for HALOPERIDOL DECANOATE
|Drug Class||Typical Antipsychotic |